OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Neurology is 75. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Error in Figure and Table	410
CC-BY Open Access Added	355
Error in Figure Legends	314
JAMA Neurology	312
Risk of Hemorrhagic Stroke in Patients With Coronavirus Disease 2019	250
Photon-Counting Computed Tomography Scan of a Cerebrospinal Fluid Venous Fistula	245
Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage	244
Acute Ischemic Stroke Care Quality Improvement	236
Autoimmune Inflammatory Astrocytopathies—Is the Spectrum Expanding?	221
Equipping AI for Unbiased and Inclusive Neurology	211
Ischemic Stroke Due to Compression of a Wandering Internal Carotid Artery by the Hyoid Bone	201
Adequate Initial Dosage and Tapering Methods of Steroids to Reduce the Total Corticosteroid Dose in Myasthenia Gravis	198
Errors in the Title, Short Title, and Additional Contributions	198
Ghrelin for Neuroprotection in Post–Cardiac Arrest Coma	197
Error in Table	171
Prevalence, Timing, and Network Localization of Emergent Visual Creativity in Frontotemporal Dementia	171
Craniocervical Junction Calcium Pyrophosphate Deposition Causing Hypoglossal Nerve Palsy	169
Error in Open Access Status	166
Error in Open Access Status	166
Error in Title	166
Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults	162
Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles	161
JAMA Neurology	157
Stay for the Eulogy	156
An Acetylcholine M₁ Receptor–Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment	155

Errors in the Author Affiliations and Figure 1 Legend	152
JAMA Neurology	149
JAMA Neurology	147
Facial Numbness, Dysarthria, Muscle Atrophy, and Weakness in a Young Patient	146
JAMA Neurology Peer Reviewers in 2020	145
Rare APOE Missense Variants—Can We Overcome APOE ε4 and Alzheimer Disease Risk?	141
MOG-IgA as a Potential Marker of Germinal Center Activity	137
Isolated Myoclonus of the Vocal Folds in Alexander Disease	137
Comments on the Evaluation of Suicidality Risk of Newer Antiseizure Medications—Reply	134
Disentangling Workflow Paradigms and Treatment Decision-Making in Acute Ischemic Stroke—Reply	126
Practical Advice on Surviving and Thriving as an Academic Physician-Neuroscientist	125
Endovascular Thrombectomy Treatment Effect in Direct vs Transferred Patients With Large Ischemic Strokes	124
Cerebral Amyloid Angiopathy and Risk of Isolated Nontraumatic Subdural Hemorrhage	124
Errors in Table 1 and Figure 2	123
Recurrent Ischemic Stroke in Patients With Atrial Fibrillation While Receiving Oral Anticoagulants	122
When Pregnancy Becomes an Inclusion Criterion in Neuroscience Research	121
Multimodal Neuroimaging of Intimal Flap in a Basilar Artery Dissection	119
Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination	114
Sequential Bilateral Vision Loss in a Woman With Scalp Tenderness and Jaw Claudication	110
I Only Want to See You—A Challenge of Long-term Clinician-Patient Relationships in Team-Based Clinical Care	109
Traumatic Brain Injury Recovery Trajectories in Patients With Disorders of Consciousness	108
Visualizing Hyperhidrosis With Water-Erasable Ink	108
Magnetic Resonance Imaging Features of Encephalitis of Scrub Typhus	107
JAMA Neurology	106
APOE Genotype and White Matter Hyperintensities in Sporadic Alzheimer Disease—Reply	104
Abandoning the Proteinopathy Paradigm in Parkinson Disease	103
Association Between Magnitude of Differential Blood Pressure Reduction and Secondary Stroke Prevention	103
Error in Figure	102
Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis	100
Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease—Estimating the True Value	99
A Young Woman With Hypertonia, Severe Scoliosis, and Encephalopathy	95
Challenges and Opportunities for Clinical Trials in Patients With Glioma	95
Bilateral Complete Ophthalmoplegia in a 50-Year-Old Man	91
New Approaches to Challenge Old Assumptions—B-Cell Depletion in Multiple Sclerosis	89
Cerebral Ultrasonography of Cytotoxic Edema in a Newborn With a Mitochondrial Disorder	88
Association of a Marker of N-Acetylglucosamine With Progressive Multiple Sclerosis and Neurodegeneration	88
A 31-Year-Old Man With Bilaterally Limited Mobility of Joints	88
Flapping Scalp Sign as a Rare and Interesting Presentation in Delayed Postoperative Tension Pneumocephalus	86
A 51-Year-Old Woman With Abnormal Corpus Callosum Signal	85
Cortical Hemiballismus Associated With an Insular and Temporal Lobe Infarct	84
Diplopia and Ptosis in an Older Woman	83
The Shrinking Roles of Clinical Research and Education for Academic Neurologists	81
Large Collaborative Registries and Real-world Data to Manage Amyloid-Related Imaging Abnormalities—Reply	79
Error in Figure 2	79
Posterior Reversible Encephalopathy Syndrome in a Child With Renovascular Hypertension	78
JAMA Neurology	77
Myocardial Infarction Bends the Curve of Age-Related Cognitive Decline, but How?	77
Error in Author Name, Figure 3A and C, and Table 1	76
Discussion on the Application of Rapid Immunoblot Assay for AQP4-IgG Detection	76
Frequency and Underlying Pathology of Pure Vascular Cognitive Impairment	75

Association Between Alberta Stroke Program Early Computed Tomography Score and Efficacy and Safety Outcomes With Endovascular Therapy in Patients With Stroke From Large-Vessel Occlusion